3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Carcinoma, Non-Small-Cell Lung
14
Neoplasm Metastasis
4
Lung Neoplasms
4
Recurrence
3
Non Small Cell Lung Cancer Metastatic
3
Meningeal Carcinomatosis
2
Brain Neoplasms
2
Thrombocytosis
1
Sexual Dysfunction, Physiological
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Neuroblastoma
1
Neoplasms
1
Neoadjuvant Non-Small Cell Lung Cancer
1
NSCLC
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Lung Diseases
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Interventions
Cyclophosphamide
48
fludarabine phosphate
32
Peripheral Blood Stem Cell Transplantation
32
Whole-Body Irradiation
26
Etoposide
23
Mycophenolic Acid
22
Rituximab
20
Filgrastim
18
Doxorubicin
18
Vincristine
16
Cyclosporine
16
Busulfan
16
Tacrolimus
15
Prednisone
15
Methotrexate
13
Melphalan
13
Antilymphocyte Serum
12
Cytarabine
11
Radiotherapy
10
Carboplatin
10
Bortezomib
9
romidepsin
8
Ifosfamide
8
Cord Blood Stem Cell Transplantation
8
Methylprednisolone
7
Lenalidomide
7
Flow Cytometry
7
Brentuximab Vedotin
7
Sirolimus
6
Everolimus
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Lymphoma, Large-Cell, Anaplastic
×
lorlatinib
×
Clear all
NCT03505554
2023-08-07
CRU3
University of Milano Bicocca
Phase 2
Unknown
12 enrolled